Our Publications

2017

  1. Klimov S, Rida PC, Aleskandarany MA, Green AR, Ellis IO, Janssen EA, Rakha EA, Aneja R. Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers. Br J Cancer. 2017 Jul 18.
  2. Ogden A, Rida PCG, Aneja R. Centrosome amplification: a suspect in breast cancer and racial disparities. Endocr Relat Cancer. 2017 May 17.
  3. Isgut M, Rao M, Yang C, Subrahmanyam V, Rida PCG, Aneja R. Application of Combination High-Throughput Phenotypic Screening and Target Identification Methods for the Discovery of Natural Product-Based Combination Drugs. Med Res Rev. 2017 May 16.
  4. Xue Y, Reid MD, Balci S, Quigley B, Muraki T, Memis B, Xia J, Hacihasanoglu E, Bedolla G, Pehlivanoglu B, Kim GE, Tajiri T, Ohike N, Aneja R, Krasinskas AM, Adsay V. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
    Am J Surg Pathol. 2017 Jul;41(7):865-876
  5. Wright N, Rida P, Aneja R. Tackling intra- and inter- tumor heterogeneity to combat triple negative breast cancer . Front Biosci (Landmark Ed). 2017 Jun 1.
  6. Mukkavalli R, Yang C, Singh T, Ghareeb A, Luthra L, Aneja R. Absorption, Metabolic Stability, and Pharmacokinetics of Ginger Phytochemicals. Molecules. 2017 Mar 30.
  7. Mittal K, Donthamsetty S, Kaur R, Yang C, Reid M, Choi D, Rida P, Aneja R. Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer. Br J Cancer. 2017 Mar 23.
  8. Ogden A, Rida P, Aneja R. Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors. Sci Rep. 2017 Mar 21.
  9. Mittal K, Choi D, Ogden A, Donthamsetty S, Melton B, Gupta M, Pannu V, Cantuaria G, Varambally S, Reid M, Jonsdottir K, Janssen E, Aleskandarany M, Ellis I, Rakha E, Rida P, Aneja R. Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells. Sci Rep. 2017 Mar 8.
  10. Ogden A, Garlapati C, Li X, Turaga R, Oprea-Ilies G, Wright N, Bhattarai S, Mittal K, Wetherilt C, Krishnamurti U, Reid M, Jones M, Gupta M, Osan R, Pattni S, Riaz A, Klimov S, Rao A, Cantuaria G, Rida P,a, Aneja R. Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer. Sci Rep. 2017 Feb 20.
  11. Saxena R, Yang C, Rao M, Turaga RC, Garlapati C, Reddy Gundala S, Myers K, Ghareeb A, Bhattarai S, Kamilinia G, Bristi S, Su D, Gadda G, Rida PC, Cantuaria G, Aneja R. Preclinical development of a non-toxic oral formulation of monoethanolamine, a lipid precursor, for prostate cancer treatment. Clin Cancer Res. 2017 Feb 6.
  12. Wright N, Xia J, Cantuaria G, Klimov S, Jones M, Neema P, II’yasova D, Krishnamurti U, Li X, Reid M D, Gupta M, Rida P C G, Osan R, Aneja R. Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations.. PLOSONE. 2017 Jan 13.
  13. Wright N, Rida P, Aneja R, Krishnamurti U, Li X, Aneja R. Targeted drugs and diagnostic assays: Companions in the race to combat ethnic disparity. Front Biosci (Landmark Ed). 2017 Jan 1.
2016

  1. Li X, Wetherlit CS, Krishnamurti U, Yang J, Ma Y, Styblo TM, Meisal JL, Peng L, Siddiqui MT, Cohen C, Aneja R. Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple Negative Breast Cancer. Am J Clinical Pathol. 2016 Oct. doi: 10.1093/ajcp/aqw134.
  2. Li XB, Krishnamurti U, Bhattarai S, Klimov S, Reid MD, O’Reagan R, Aneja R.Biomarker Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer. Am J Clinical Pathol. 2016 Jun. doi: 10.1093/ajcp/aqw045.
  3. Zhang L, Ogden A, Aneja R, Zhou J. Diverse roles of HDAC6 in viral infection. Implications for antiviral therapy. Pharmacol Ther. 2016 Apr 23. doi: 10.1016/j.pharmthera.2016.04.005.
  4. Mittal K, Choi Da H, Klimov S, Pawar S, Mitra AK, Gupta MV, Sams R, Cantuaria G, Rida PC, Aneja R. A Centrosome Clustering Protein, KIFC1, Predicts Aggressive Disease Course in Serous Ovarian Adenocarcinomas. J Ovarian Res. 2016 Mar 18. doi: 10.1186/s13048-016-0224-0.
  5. Saxena R, Rida PC, Kucuk O, Aneja R. Ginger augmented chemotherapy: A novel multitarget non-toxic approach for cancer management. Mol Nutr Food Res. 2016 Feb 4. doi: 10.1002/mnfr.201500955. [Epub ahead of print]

2015

  1. Xie S, Ogden A, Aneja R, Zhou J. Microtubule-Binding Proteins as Promising Biomarkers of Paclitaxel Sensitivity in Cancer Chemotherapy. Med Res Rev. 2015 Sep 1. doi: 10.1002/med.21378. [Epub ahead of print] (IF: 8.4)
  2. Rida PC, Cantuaria G, Reid MD, Kucuk O, Aneja R. How to be Good at Being Bad: Centrosome Amplification and Mitotic Propensity drive Intratumoral Heterogeneity. Cancer Metastasis Rev. 2015 Sep 10. [Epub ahead of print] (IF: 7.7)
  3. Nimesh H, Tiwari V, Yang C, Gundala SR, Chuttani K, Hazari PP, Mishra AK, Sharma A, Lal J, Katyal A, Aneja R, Tandon V. Preclinical Evaluation of DMA, a Bisbenzimidazole as Radioprotector: Toxicity, Pharmacokinetics and Biodistribution Studies in Balb/c Mice. Mol Pharmacol. 2015 Aug 3.
  4. Rida PC, LiVecche D, Ogden A, Zhou J, Aneja R. The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications. Med Res Rev. 2015 Sep;35(5):1072-96. (IF: 8.4)
  5. McBride M, Rida PC, Aneja, R. Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity. Mol Aspects Med. 2015 May 27. (IF 11.2)
  6. Ogden A, Rida PC, Knudsen B, Kucuk O, Aneja R. Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse. Cancer Lett. 2015 Jul 13. (IF 5.6)
  7. Mittal K, Ogden A, Reid MD, Rida PC, Varambally S, Aneja R. Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma. Cell Cycle. 2015 Jul 7 (Ahead of print)
  8. Mukkavilli R, Gundala SR, Yang C, Jadhav GR, Vangala S, Reid MD, Aneja R. Noscapine recirculates enterohepatically and induces self-clearance. Eur J Pharm Sci. 2015 May 28;77:90-99. (IF 3.3)
  9. Kaur K, Sodhi RK, Katyal A, Aneja R, Jain UK, Katare OP, Madan J. Wheat germ agglutinin anchored chitosan microspheres of reduced brominated derivative of noscapine ameliorated acute inflammation in experimental colitis. Colloids Surf B Biointerfaces. 2015 Aug 1;132:225-35. (IF 4.4)
  10. Yang C, Gundala SR, Mukkavilli R, Vangala S, Reid MD, Aneja R. Synergistic interaction among flavonoids and acetogenins in Graviola (Annona Muricata) leaves confer protection against prostate cancer. Carcinogenesis. 2015 Jun;36(6):656-65. (IF: 5.3)
  11. Mishra R, Gundala SR, Karna P, Lopus M, Gupta KK, Mulpuri N, Hamelberg D, Tandon V, Reid MD, Aneja R. Design, Synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents. Bioorg Med Chem Lett. 2015 May 15;25(10):2133-40. (IF: 2.3)
  12. Pannu V, Mittal K, Cantuaria G, Reid MD, Li X, Donthamsetty S, Bowen N, McBride M, Klimov S, Osan R, Gupta MV, Rida PC, Aneja R. Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers. Oncotarget. 2015 Apr 30;6(12):10487-97. (IF: 6.6) PDF
  13. Pannu V, Rida PC, Ogden A, Turaga R, Donthamsetty S, Bowen N, Rudd K, Gupta MV, Reid MD, Cantuaria G, Walczak C, Aneja R. HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients. Oncotarget 2015 Mar 20;6(8):6076-91. (IF: 6.6) PDF
  14. Ogden A, Rida PC, Reid MD, Kucuk O, Aneja R. Die-hard survivors: Heterogeneity in apoptotic thresholds may underlie chemoresistance. Expert Rev Anticancer Ther. 2015 Mar;15(3):277-81 (IF: 2.7) PDF

2014

  1. Madan J, Gundala SR, Baruah B, Nagaraju M, Yates C, Turner T, Rangari V, Hamelberg D, Reid MD, Aneja R. Cyclodextrin complexes of reduced bromonoscapine in guar gum microspheres enhance colonic drug delivery. Mol. Pharm. 2014 Dec 1;11(12):4339-49. (IF: 4.8)
  2. Yang Y, Ran J, Liu M, Li D, Li Y, Shi X, Meng D, Pan J, Ou G, Aneja R, Sun SC, Zhou J. CYLD mediates ciliogenesis in multiple organs by deubiquitinating Cep70 and inactivating HDAC6. Cell Res. 2014 Nov;24(11):1342-53. (IF: 12.4) PDF
  3. Pannu V, Rida PC, Celik B, Turaga R, Ogden A, Cantuaria G, Gopalakrishnan J, Aneja R. Centrosome declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells. Cell Death Dis. 2014 Nov 20;5:e1538. (IF: 5.17) PDF
  4. Henary M, Narayana L, Ahad S, Gundala SR, Mukkavilli R, Sharma V, Owens EA, Yadav Y, Nagaraju M, Hamelberg D, Tandon V, Panda D, Aneja R. Novel third-generation water-soluble noscapine analogs as superior microtubule-interfering agents with enhanced antiproliferative activity. Biochem Pharmacol. 2014 Nov15;92(2):192-205. (IF: 5.0)
  5. Mukkavilli R, Gundala SR, Yang C, Donthamsetty, S, Cantuaria G, Jadhav GR, Vangala S, Reid MD, Aneja R. Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics. PLoS ONE. 2014 Sep 24;9(9):e108386. (IF: 3.53) PDF
  6. Gundala SR, Yang C, Mukkavilli R, Paranjpe R, Brahmbhatt M, Pannu V, Cheng A, Reid MD, Aneja R. Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis. Toxicol. Appl. Pharmacol. 2014 Oct 1;280(1):86-96. (IF: 3.63) PDF
  7. Pawar S, Donthamsetty S, Pannu V, Rida PC, Ogden A, Bowen N, Osan R, Cantuaria G, Aneja R. KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: Delineating protein interaction networks and signaling circuitries. J Ovarian Res. 2014 May 12;7:53. (IF: 2.4) PDF
  8. Ogden A, Rida PC, Reid MD, Aneja R. Interphase microtubules: chief casualties in the war on cancer? Drug Discov Today. 2014 Jul;19(7):824-829. (IF: 6.7) PDF
  9. Donthamsetty S, Brahmbhatt M, Pannu V, Rida PC, Ramarathinam S, Ogden A, Cheng A, Singh KK, Aneja R. Mitochondrial genome regulates mitotic fidelity by maintaining centrosomal homeostasis. Cell Cycle. 2014 Jul 1;13(13):2056-63. (IF: 5.24) PDF
  10. Ogden A, Cheng A, Rida PC, Pannu V, Osan R, Clewley R, Aneja R. Quantitative multi-parametric evaluation of centrosome declustering drugs: Centrosome amplication, mitotic phenotype, cell cycle and death. Cell Death and Disease. 2014 May 1;5:e1204. (IF: 5.17) PDF
  11. Gundala SR, Mukkavilli R, Yang C, Yadav P, Tandon V, Vangala S, Prakash S, Aneja R. Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract. Carcinogenesis. 2014 Jun;35(6):1320-9. (IF: 5.26) PDF
  12. Gundala SR, Aneja R. Piper betel leaf: A reservoir of potential xenohormetic nutraceuticals with cancer-fighting properties. Cancer Prev Res. 2014 May;7(5):477-86. (IF: 5.26) PDF
  13. Yadav Y, Owens EA, Sharma V, Aneja R, Henary M. Synthesis and evaluation of antiproliferative activity of a novel series of hydroxychavicol analogs. Eur J Med Chem. 2014 Mar 21;75:1-10. (IF: 3.43)
  14. Madan J, Gundala SR, Kasetti Y, Bharatam PV, Aneja R, Katyal A, Jain UK. Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy. Anticancer Drugs. 2014 Jul;25(6):704-16. (IF: 1.89)

2013

  1. Gundala SR, Yang C, Lakshminarayana N, Asif G, Gupta MV, Shamsi S, Aneja R. Polar biophenolics in sweet potato greens extract synergize to inhibit prostate cancer cell proliferation and in vivo tumor growth. Carcinogenesis. 2013 Sep;34(9):2039-49. (IF: 5.26) PDF
  2. Paranjpe R, Gundala SR, Lakshminarayana N, Sagwal A, Asif G, Pandey A, Aneja R. Piper betel leaf extract: Anticancer benefits and bio-guided fractionation to identify active principles for prostate cancer management. Carcinogenesis. 2013 Jul;34(7):1558-66. IF: 5.26) PDF
  3. Madan J, Pandey RS, Jain UK, Katare OP, Aneja R, Katyal A. Sterically stabilized gelatin microassemblies of noscapine enhance cytotoxicity, apoptosis and drug delivery in lung cancer cells. Colloids Surf B Biointerfaces. 2013 Jul 1;107:235-44. (IF: 4.28)
  4. Brahmbhatt M, Gundala SR, Asif G, Shamsi SA, Aneja R. Ginger phytochemicals exhibit synergy to inhibit prostate cancer cell proliferation. Nutr Cancer. 2013 Feb;65(2):263-72. IF: 2.63) PDF
  5. Ogden A, Rida PC, Aneja R. Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration. Cancer Metastasis Rev. 2013 Jun;32(1-2):269-87. (IF: 6.44) PDF

2012

  1. Pannu V, Rida PC, Ogden A, Clewley R, Cheng A, Karna P, Lopus M, Mishra RC, Zhou J, Aneja R. Induction of robust de novo centrosome amplification, high-grade spindle multipolarity and metaphase catastrophe: A novel chemotherapeutic approach. Cell Death and Disease 2012 Jul 12;3:e346. (IF: 5.17) PDF
  2. Ogden A, Rida PC, Aneja R. Let’s huddle to prevent a muddle: Centrosome declustering as an attractive anticancer strategy. Cell Death Differ. 2012 Aug;19(8):1255-67. (IF: 8.38) PDF
  3. Karna P, Rida PC, Gao J, Gupta M, Fritz A, Werner E, Yates C, Zhou J, Aneja R. A novel microtubule-modulating agent inhibits angiogenesis by repressing the HIF-1alpha axis and disrupting cell polarity and migration. Carcinogenesis 2012 Sep;33(9):1769-81. (IF: 5.26) PDF
  4. Madan J, Baruah B, Mulpuri N, Abdalla MO, Yates C, Turner C, Rangari V, Hamelberg D, Aneja R. Molecular cycloencapsulation augments solubility and improves therapeutic index of brominated noscapine in prostate cancer cells. Mol Pharm 2012 May 7;9(5):1470-80. (IF: 4.7) PDF
  5. Kaur N, Ranjan A, Tiwari V, Aneja R, Tandon V. DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells. PLoS One. 2012 Jun 22;7(6):e39426. (IF: 3.53) PDF
  6. Shi X, Liu M, Li D, Wang J, Aneja R, Zhou J. Cep70 contributes to angiogenesis by modulating microtubule rearrangement and stimulating cell polarization and migration. Cell Cycle. 2012 Apr 15;11(8):1554-63. (IF: 5)
  7. Karna P, Chagani S, Gundala SR, Rida PC, Asif G, Sharma V, Gupta MV, and Aneja R. Benefits of whole ginger extract in prostate cancer. Br. J Nutr. 2012 Feb;107(4):473-84. (IF: 3.3) PDF
  8. Naik PK, Lopus M, Aneja R, Vangapandu SN, Joshi HC. In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin). J Comput Aided Mol Des. 2012 Feb;26(2):233-47. (IF: 2.78)
  9. Henary M, Pannu V, Owens EA, Aneja R. Near infrared active heptacyanine dyes with unique cancer-imaging and cytotoxic properties. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1242-6. (IF: 2.33)

2011

  1. Karna P, Rida CGP, Pannu V, Gupta KK, Dalton BW, Joshi HC, Yang VW, Zhou J, Aneja R. A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering. Cell Death Differ. 2011 Apr;18(4):632-44. (IF: 8.38) PDF
  2. Karna P, Gundala SR, Gupta MV, Shamsi SA, Pace RD, Yates C, Narayan S, Aneja R. Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo. Carcinogenesis. 2011 Dec;32(12):1872-80. (IF: 5.26) PDF
  3. Stanton R, Gernert KM, Nettles JH, Aneja R. Drugs that target dynamic microtubules: A new molecular perspective. Med. Res. Rev. 2011 May;31(3):443-81. (IF: 8.13) PDF
  4. Mishra RC, Karna P, Gundala SR, Pannu V, Stanton RA, Gupta KK, Robinson MH, Lopus M, Wilson L, Henary M, Aneja R. Second generation benzofuranone ring substituted noscapine analogs: Synthesis and biological evaluation. Biochem Pharmacol. 2011 Jul 15;82(2):110-21. (IF: 4.65)
  5. Pannu V, Karna P, Sajja HK, Shukla D, Aneja R. Synergistic antimicrotubule therapy for prostate cancer. Biochem Pharmacol. 2011 Feb 15;81(4):478-87. (IF: 4.65)
    (Invited commentary on this article appeared in Feb 2011 volume of Nature Reviews Urology Farley SJ. Prostate cancer: Synergistic sequential enhancement of docetaxel. Nat Rev Urol. 2011 Feb;8(2) )
  6. Abdalla MO, Karna P, Sajja HK, Mao H, Yates C, Turner T, Aneja R. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy. J Control Release 2011 Feb 10;149(3):314-22. (IF: 7.26) PDF
  7. Shi X, Sun X, Liu M, Li D, Aneja R, Zhou J. CEP70 protein interacts with {gamma}-tubulin to localize at the centrosome and is critical for mitotic spindle assembly. J Biol Chem. 2011 Sep 23;286(38):33401-8. (IF: 4.6) PDF
  8. Long M, Karna P, Rida PC, Aneja R. Hypoxia mediates primary cilium disassembly via downregulation of the tumor suppressor CYLD. The FASEB Journal. 2011 ;25:728.1 (IF: 5.4)
  9. Yates C, Sharp S, Jones J, Topps D, Coleman M, Aneja R, Jaynes J, Turner T. LHRH-conjugated lytic peptides directly target prostate cancer cells. Biochem Pharmacol. 2011 Jan 1;81(1):104-10. (IF: 4.65) PDF
  10. Madan J, Dhiman N, Sardana S, Aneja R, Chandra R, Katyal A. Long-circulating poly(ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine: preparation, in-vitro characterization, structure elucidation, pharmacokinetics, and cytotoxicity analyses. Anticancer Drugs. 2011 Jul;22(6):543-55. (IF: 1.89)
  11. Huo L, Li D, Sun X, Shi X, Karna P, Yang W, Liu M, Qiao W, Aneja R, Zhou J. Regulation of Tat acetylation and transactivation activity by the microtubule-associated deacetylase HDAC6. J Biol Chem. 2011 Mar 18;286(11):9280-6. (IF: 4.60) PDF
  12. Naik PK, Chatterji BP, Vangapandu SN, Aneja R, Chandra R, Kanteveri S, Joshi HC. Rational design, synthesis and biological evaluations of amino-noscapine: a high affinity tubulin-binding noscapinoid. J Comput Aided Mol Des. 2011 May;25(5):443-54. (IF: 2.78)
  13. Jaiswal AS, Banerjee S, Aneja R, Sarkar FH, Ostrov DA, Narayan S. DNA polymerase beta as a novel target for chemotherapeutic intervention of colorectal cancer. PLoS One. 2011 Feb 2;6(2):e16691. (IF: 3.53) PDF

2010

  1. Karna P, Zughaier S, Pannu V, Simmons R, Narayan S, Aneja R. Induction of reactive oxygen species-mediated autophagy by a novel microtubule-modulating agent. J Biol Chem. 2010 Jun 11;285(24):1837-48. (IF: 5.58) PDF
  2. Josson S, Sharp S, Sung SY, Johnstone PA, Aneja R, Wang R, Gururajan M, Turner T, Chung LW, Yates C. Tumor-Stromal Interactions Influence Radiation Sensitivity in Epithelial- versus Mesenchymal-Like Prostate Cancer Cells. J Oncol. 2010 Jul 29. PDF
  3. Zughaier S, Karna P, Stephens D, Aneja R. Potent anti-inflammatory activity of novel microtubule-modulating brominated noscapine analogs. PLoS One. 2010 Feb 11;5(2):e9165. (IF: 3.53) PDF
  4. Aneja R, Miyagi T, Karna P, Ezell T, Shukla D, Vij Gupta M, Yates C, Chinni SR, Zhau H, Chung LW, Joshi HC. A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells. Eur J Cancer. 2010 Jun;46(9):1668-78. (IF: 4.81) PDF
  5. Aneja R, Asress S, Dhiman N, Awasthi A, Rida PC, Arora SK, Zhou J, Glass JD, Joshi HC. Non-toxic melanoma therapy by a novel tubulin-binding agent. Int J Cancer. 2010 Jan 1;126(1):256-65. (IF: 5) PDF
  6. Aneja R, Luthra PM, Ahuja S. High-performance liquid chromatography separation of enantiomers of mandelic acid and its analogs on a chiral stationary phase. Chirality. 2010 May 15;22(5):479-85. (IF: 1.72)
  7. Abdalla MO, Aneja R, Dean D, Rangari V, Russell A, Jaynes J, Yates C, Turner T. Synthesis and characterization of noscapine loaded magnetic polymeric nanoparticles J. Magn Magn Mater. 2010 Jan 1;322(2):190-196. (IF: 2) PDF
  8. Madan J, Dhiman N, Parmar VK, Sardana S, Bharatam PV, Aneja R, Chandra R, Katyal A. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics. Cancer Chemother Pharmacol. 2010 Feb;65(3):537-48. (IF: 2.57)

2009

  1. Karna P, Sharp S, Yates C, Prakash S, Aneja R. EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells. Mol. Cancer. 2009 Oct 30;8:93. (IF: 5.4) PDF
  2. Jaiswal AS, Aneja R, Connors SK, Joshi HC, Multani AS, Pathak S, Narayan S. 9-bromonoscapine-induced mitotic arrest of cigarette smoke condensate-transformed breast epithelial cells. J Cell Biochem. 2009 Apr 15;106(6):1146-56. (IF: 4.6)

2008

  1. Liu M, Aneja R, Sun X, Xie S, Wang H, Wu X, Dong JT, Li M, Joshi HC, Zhou J. Parkin regulates Eg5 expression by Hsp70 ubiquitination-dependent inactivation of the c-Jun NH2-terminal kinase. J Biol Chem. 2008 Dec 19;283(51):35783-8. (IF: 4.6) PDF
  2. Aneja R, Liu M, Yates C, Gao J, Dong X, Zhou B, Vangapandu SN, Zhou J, Joshi HC. Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent. Cancer Res. 2008 Mar 1:68(5):1495-503. (IF: 9.28) PDF
  3. Liu M, Aneja R, Wang H, Sun L, Dong X, Huo L, Joshi H, Zhou J. Modulation of multidrug resistance in cancer cells by the E3 ubiquitin ligase seven-in-absentia homologue 1. J Pathol. 2008 Mar;214(4):508-14. (IF: 7.33)
  4. Kumaran D, Udayabanu M, Kumar M, Aneja R, Katyal A. Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats. Neuroscience. 2008 Aug 26;155(3):626-39. (IF: 3.32)
  5. Kumaran D, Udayabanu M, Nair RU, Aneja R, Katyal A. Benzamide protects delayed neuronal death and behavioural impairment in a mouse model of global cerebral ischemia. Behav Brain Res. 2008 Oct 10;192(2):178-84. (IF: 3.39)
  6. Udayabanu M, Kumaran D, Nair RU, Srinivas P, Bhagat N, Aneja R, Katyal A. Nitric oxide associated with iNOS expression inhibits acetylcholinesterase activity and induces memory impairment during acute hypobaric hypoxia. Brain Res. 2008 Sep 16;1230:138-49. (IF: 2.82)

Publications prior to 2008 are available on Pubmed.